Following a review by the Advisory Committee on Borderline Substances (ACBS) back in 2018, the probiotic food supplements VSL#3® and Vivomixx® were removed from Part XV of the Drug Tariff in England. The Committee concluded that the evidence did not sufficiently demonstrate that the products are clinically effective.
VSL#3 & Vivomixx removed from Drug Tariff
Posted: Wednesday, February 16, 2022
Category - Medicines Update